For example, a study by Vadakekolathu et al. showed that interferon-gamma (IFN-γ)-related mRNA profiles predicted chemotherapy resistance and the response of primary refractory/relapsed AML to flotezumab immunotherapy [57]. This evidence concerns the gene IFNG and acute myeloid leukemia.